Lincoln Pharmaceuticals consolidated net profit declines 24.12% in the September 2025 quarter
(13 Nov 2025)

Back
Net profit of Lincoln Pharmaceuticals declined 24.12% to Rs 19.98 crore in the quarter ended September 2025 as against Rs 26.33 crore during the previous quarter ended September 2024. Sales rose 1.33% to Rs 163.36 crore in the quarter ended September 2025 as against Rs 161.21 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales163.36161.21 1
OPM %15.5717.60 -
PBDT32.4338.01 -15
PBT28.8134.78 -17
NP19.9826.33 -24

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew